818 related articles for article (PubMed ID: 18923524)
81. Alternative transcription initiation leads to expression of a novel ALK isoform in cancer.
Wiesner T; Lee W; Obenauf AC; Ran L; Murali R; Zhang QF; Wong EW; Hu W; Scott SN; Shah RH; Landa I; Button J; Lailler N; Sboner A; Gao D; Murphy DA; Cao Z; Shukla S; Hollmann TJ; Wang L; Borsu L; Merghoub T; Schwartz GK; Postow MA; Ariyan CE; Fagin JA; Zheng D; Ladanyi M; Busam KJ; Berger MF; Chen Y; Chi P
Nature; 2015 Oct; 526(7573):453-7. PubMed ID: 26444240
[TBL] [Abstract][Full Text] [Related]
82. Genome-wide linkage analysis to identify genetic modifiers of ALK mutation penetrance in familial neuroblastoma.
Devoto M; Specchia C; Laudenslager M; Longo L; Hakonarson H; Maris J; Mossé Y
Hum Hered; 2011; 71(2):135-9. PubMed ID: 21734404
[TBL] [Abstract][Full Text] [Related]
83. Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma group.
Mazzocco K; Defferrari R; Sementa AR; Garaventa A; Longo L; De Mariano M; Esposito MR; Negri F; Ircolò D; Viscardi E; Luksch R; D'Angelo P; Prete A; Castellano A; Massirio P; Erminio G; Gigliotti AR; Tonini GP; Conte M
Pediatr Blood Cancer; 2015 Oct; 62(10):1725-32. PubMed ID: 25925003
[TBL] [Abstract][Full Text] [Related]
84. The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma.
Berry T; Luther W; Bhatnagar N; Jamin Y; Poon E; Sanda T; Pei D; Sharma B; Vetharoy WR; Hallsworth A; Ahmad Z; Barker K; Moreau L; Webber H; Wang W; Liu Q; Perez-Atayde A; Rodig S; Cheung NK; Raynaud F; Hallberg B; Robinson SP; Gray NS; Pearson AD; Eccles SA; Chesler L; George RE
Cancer Cell; 2012 Jul; 22(1):117-30. PubMed ID: 22789543
[TBL] [Abstract][Full Text] [Related]
85. An enzyme-linked immunosorbent assay to screen for inhibitors of the oncogenic anaplastic lymphoma kinase.
Gunby RH; Tartari CJ; Porchia F; Donella-Deana A; Scapozza L; Gambacorti-Passerini C
Haematologica; 2005 Jul; 90(7):988-90. PubMed ID: 15996942
[TBL] [Abstract][Full Text] [Related]
86. Low Frequency ALK Hotspots Mutations In Neuroblastoma Tumours Detected By Ultra-deep Sequencing: Implications For ALK Inhibitor Treatment.
Javanmardi N; Fransson S; Djos A; Sjöberg RM; Nilsson S; Truvé K; Kogner P; Martinsson T
Sci Rep; 2019 Feb; 9(1):2199. PubMed ID: 30778092
[TBL] [Abstract][Full Text] [Related]
87. The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness.
Mus LM; Lambertz I; Claeys S; Kumps C; Van Loocke W; Van Neste C; Umapathy G; Vaapil M; Bartenhagen C; Laureys G; De Wever O; Bexell D; Fischer M; Hallberg B; Schulte J; De Wilde B; Durinck K; Denecker G; De Preter K; Speleman F
Sci Rep; 2020 Jan; 10(1):218. PubMed ID: 31937834
[TBL] [Abstract][Full Text] [Related]
88. Deep Sequencing Reveals Occurrence of Subclonal ALK Mutations in Neuroblastoma at Diagnosis.
Bellini A; Bernard V; Leroy Q; Rio Frio T; Pierron G; Combaret V; Lapouble E; Clement N; Rubie H; Thebaud E; Chastagner P; Defachelles AS; Bergeron C; Buchbinder N; Taque S; Auvrignon A; Valteau-Couanet D; Michon J; Janoueix-Lerosey I; Delattre O; Schleiermacher G
Clin Cancer Res; 2015 Nov; 21(21):4913-21. PubMed ID: 26059187
[TBL] [Abstract][Full Text] [Related]
89. Newly-derived neuroblastoma cell lines propagated in serum-free media recapitulate the genotype and phenotype of primary neuroblastoma tumours.
Bate-Eya LT; Ebus ME; Koster J; den Hartog IJ; Zwijnenburg DA; Schild L; van der Ploeg I; Dolman ME; Caron HN; Versteeg R; Molenaar JJ
Eur J Cancer; 2014 Feb; 50(3):628-37. PubMed ID: 24321263
[TBL] [Abstract][Full Text] [Related]
90. Integrative genomics identifies LMO1 as a neuroblastoma oncogene.
Wang K; Diskin SJ; Zhang H; Attiyeh EF; Winter C; Hou C; Schnepp RW; Diamond M; Bosse K; Mayes PA; Glessner J; Kim C; Frackelton E; Garris M; Wang Q; Glaberson W; Chiavacci R; Nguyen L; Jagannathan J; Saeki N; Sasaki H; Grant SF; Iolascon A; Mosse YP; Cole KA; Li H; Devoto M; McGrady PW; London WB; Capasso M; Rahman N; Hakonarson H; Maris JM
Nature; 2011 Jan; 469(7329):216-20. PubMed ID: 21124317
[TBL] [Abstract][Full Text] [Related]
91. High expression of ncRAN, a novel non-coding RNA mapped to chromosome 17q25.1, is associated with poor prognosis in neuroblastoma.
Yu M; Ohira M; Li Y; Niizuma H; Oo ML; Zhu Y; Ozaki T; Isogai E; Nakamura Y; Koda T; Oba S; Yu B; Nakagawara A
Int J Oncol; 2009 Apr; 34(4):931-8. PubMed ID: 19287950
[TBL] [Abstract][Full Text] [Related]
92. Anaplastic Lymphoma Kinase: role in specific tumours, and development of small molecule inhibitors for cancer therapy.
Ardini E; Magnaghi P; Orsini P; Galvani A; Menichincheri M
Cancer Lett; 2010 Dec; 299(2):81-94. PubMed ID: 20934803
[TBL] [Abstract][Full Text] [Related]
93. Aberrations of NEGR1 on 1p31 and MYEOV on 11q13 in neuroblastoma.
Takita J; Chen Y; Okubo J; Sanada M; Adachi M; Ohki K; Nishimura R; Hanada R; Igarashi T; Hayashi Y; Ogawa S
Cancer Sci; 2011 Sep; 102(9):1645-50. PubMed ID: 21624008
[TBL] [Abstract][Full Text] [Related]
94. Identification of ALK germline mutation (3605delG) in pediatric anaplastic medulloblastoma.
Coco S; De Mariano M; Valdora F; Servidei T; Ridola V; Andolfo I; Oberthuer A; Tonini GP; Longo L
J Hum Genet; 2012 Oct; 57(10):682-4. PubMed ID: 22810114
[TBL] [Abstract][Full Text] [Related]
95. Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways.
Van den Eynden J; Umapathy G; Ashouri A; Cervantes-Madrid D; Szydzik J; Ruuth K; Koster J; Larsson E; Guan J; Palmer RH; Hallberg B
Sci Signal; 2018 Nov; 11(557):. PubMed ID: 30459281
[TBL] [Abstract][Full Text] [Related]
96. Mutation and copy number detection in human cancers using a custom genotyping assay.
Moy C; Aziz MU; Greshock J; Szabo S; McNeil E; Jing J; Conway T; Degenhardt Y; Wooster R; Bachman K
Genomics; 2011 Oct; 98(4):296-301. PubMed ID: 21600279
[TBL] [Abstract][Full Text] [Related]
97. Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types.
Stoica GE; Kuo A; Powers C; Bowden ET; Sale EB; Riegel AT; Wellstein A
J Biol Chem; 2002 Sep; 277(39):35990-8. PubMed ID: 12122009
[TBL] [Abstract][Full Text] [Related]
98. NeuroD1 promotes neuroblastoma cell growth by inducing the expression of ALK.
Lu F; Kishida S; Mu P; Huang P; Cao D; Tsubota S; Kadomatsu K
Cancer Sci; 2015 Apr; 106(4):390-6. PubMed ID: 25652313
[TBL] [Abstract][Full Text] [Related]
99. Anaplastic lymphoma kinase expression in neuroblastomas and its relationship with genetic, prognostic, and predictive factors.
Berthier A; Piqueras M; Villamón E; Berbegall A; Tadeo I; Castel V; Navarro S; Noguera R
Hum Pathol; 2011 Feb; 42(2):301-2. PubMed ID: 21238789
[No Abstract] [Full Text] [Related]
100. Integrated proximal proteomics reveals IRS2 as a determinant of cell survival in ALK-driven neuroblastoma.
Emdal KB; Pedersen AK; Bekker-Jensen DB; Lundby A; Claeys S; De Preter K; Speleman F; Francavilla C; Olsen JV
Sci Signal; 2018 Nov; 11(557):. PubMed ID: 30459283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
